"In our study, we found a high rate of non-treatment of peripheral artery disease along with higher levels of mortality in these patients," said Viet T. Le, DMSc, MPAS, PA-C, primary investigator ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

“In our study, we found a high rate of non-treatment of peripheral artery disease along with higher levels of mortality in these patients,” said Viet T. Le, DMSc, MPAS, PA-C, primary ...

The dangers of clogged arteries extend well beyond the workings of your heart. Peripheral artery disease makes it difficult for you to walk, causes non-healing sores in your legs or feet, and creates ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

peripheral artery disease the third leading cause of death from atherosclerotic disease. "In our study, we found a high rate of non-treatment of peripheral artery disease along with higher levels of ...

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

No treatment-related deaths were reported. “These findings support the use of semaglutide in people with peripheral artery disease and type 2 diabetes and suggest that semaglutide should be ...

In our study, we found a high rate of non-treatment of peripheral artery disease along with higher levels of mortality in these patients. Based on our findings, we think health systems can do a ...